How are you considering the cost impact of subcutaneous pertuzumab/trastuzumab in your treatment planning?  

Yes, this is an important institutional and patient consideration, although this is mostly in the hands of our Pharmacy Departments and administrative personnel who have the best financial information

As budgets become increasingly tight at many institutions around the nation due to current events, cost of purchasing a newly FDA approved drug may be under scrutiny. It is important for institutions to evaluated their local insurance policies to ensure their patients will be covered prior to starti...

I have been utilizing it now instead of IV HP in almost all my patients as it really cuts down on infusion time, and data from preference studies suggest patients generally preferred the SQ treatment over IV.